— Know what they know.
Not Investment Advice

ATRC NASDAQ

AtriCure, Inc.
1W: +2.4% 1M: +4.3% 3M: -11.5% YTD: -26.6% 1Y: -15.4% 3Y: -41.2% 5Y: -60.0%
$28.29
-0.53 (-1.84%)
After Hours: $28.38 (+0.09, +0.34%)
Weekly Expected Move ±7.0%
$24 $26 $28 $30 $32
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Neutral · Power 59 · $1.4B mcap · 49M float · 1.47% daily turnover · Short 74% of daily vol

Cash Flow Trends

Operating Cash Flow
$57M +369.8% ▲
Capital Expenditures
$9M +61.4% ▲
5Y CAGR: +11.5%
Free Cash Flow
$48M +529.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$11M -60.6% ▼
Net Change in Cash
$45M +16.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$50M-$46M-$30M$0-$11M
Depreciation & Amort.$10M$12M$15M$0$21M
Stock-Based Comp.$28M$29M$36M$0$45M
Change in Working Capital-$5M-$19M-$18M-$18M-$4M
Other Non-Cash Items-$182M$3M$3M$31M$8M
Operating Cash Flow-$14M-$22M$4M$12M$57M
— Investing Activities —
Capital Expenditures-$10M-$17M-$12M$0-$9M
Acquisitions (Net)-$33M-$44M$0$0$0
Investment Purchases-$173M-$25M$0$0$0
Investment Sales$206M$86M$64M$0$0
Other Investing$33M$44M-$30M$30M-$6M
Investing Cash Flow$24M$44M$22M$30M-$15M
— Financing Activities —
Net Debt Issuance-$816K-$899K-$992K-$2M$5M
Stock Repurchased-$18M-$12M-$7M-$7M-$11M
Dividends Paid$0$0$0$0$0
Other Financing$11M$6M$8M$5M$0
Financing Cash Flow-$8M-$7M-$32K-$4M$1M
Net Change in Cash$2M$14M$26M$38M$45M
Cash End of Period$44M$58M$84M$123M$167M
Free Cash Flow-$24M-$39M-$38M-$11M$48M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms